| Biomarker ID | 1198 |
| PMID | 23921786 |
| Year | 2014 |
| Biomarker | Angiogenin |
| Biomarker Basis | Concentration based (pg/ml) |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulated in Patients with PCa (median): [Cancer 487,500 vs. Non Cancer: 414,800) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Prostate Cancer Vs Non Cancer |
| Type of Biomarker | Diagnostic |
| Cohort | 241 patients such that 151 did not have cancer and 90 did were included in the study |
| Senstivity | 9000% |
| Specificity | 1460% |
| AUC | 0.59 (95% CI: 0.50–0.68) |
| Accuracy | NA |
| Level Of Significance | p = 0.008 |
| Method Used | ELISA |
| Clinical | No |
| Remarks | Angiogenin < 230 000 was taken as cut off for calculating Sensitivity and Specificity. (Not for AUC) |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | ANG |